Fusion Antibodies interim revenue falls on-year but outlook optimistic
(Alliance News) - Fusion Antibodies PLC on Thursday said it remains on plans with its strategic goals as it anticipates a stronger second financial half. Read More
| Price | 13.25p on 24-10-2025 at 11:35:33 |
|---|---|
| Change | -0.75p -5.36% |
| Buy | 13.50p |
| Sell | 13.00p |
| Last Trade: | Buy 7,370.00 at 13.50p |
| Day's Volume: | 597,344 |
| Last Close: | 14.00p |
| Open: | 14.00p |
| ISIN: | GB00BDQZGK16 |
| Day's Range | 13.25p - 14.00p |
| 52wk Range: | 3.95p - 20.50p |
| Market Capitalisation: | £15.06m |
| VWAP: | 13.54514p |
| Shares in Issue: | 113.66m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Fusion Antibodies (FAB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 7,370 | 13.50p | Ordinary |
12:35:32 - 24-Oct-25 |
| Buy* | 1,245 | 13.49p | Ordinary |
12:14:42 - 24-Oct-25 |
| Buy* | 742 | 13.495p | Ordinary |
12:05:08 - 24-Oct-25 |
| Buy* | 20,000 | 13.50p | Ordinary |
12:00:43 - 24-Oct-25 |
| Buy* | 1,000 | 13.40p | Ordinary |
11:58:34 - 24-Oct-25 |
| Buy* | 221 | 13.40p | Ordinary |
11:43:18 - 24-Oct-25 |
| Sell* | 48 | 13.00p | SI Trade |
11:40:43 - 24-Oct-25 |
| Buy* | 4 | 13.90p | Ordinary |
11:33:36 - 24-Oct-25 |
| Buy* | 4 | 13.90p | Ordinary |
11:25:48 - 24-Oct-25 |
| Buy* | 5,000 | 13.80p | Ordinary |
10:33:58 - 24-Oct-25 |
Fusion Antibodies (FAB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Oct 2025 1:31 pm | RNS | Result of AGM |
| 16th Oct 2025 7:00 am | RNS | AGM statement and H1 trading update |
| 8th Oct 2025 7:00 am | RNS | Contract win |
| 19th Sep 2025 12:58 pm | RNS | Posting of Annual Report & Notice of AGM |
| 17th Sep 2025 7:00 am | RNS | OptiMAL R&D Update |
| 8th Sep 2025 7:00 am | RNS-R | Belfast investor presentation |
| 4th Sep 2025 7:00 am | RNS | Final Results |
| 28th Aug 2025 7:00 am | RNS | Contract Win |
| 27th Aug 2025 7:00 am | RNS | Contract wins with existing client |
| 26th Aug 2025 7:00 am | RNS-R | Investor presentations |